Product Details

Product Data Sheet

Tadalafil
CAS No. :	171596-29-5
Formula:	C22H19N3O4
M.Wt:	389.4
Synonyms:	Cialis,ICOS 351,Ic351,IC 351,IC-351 Metabolism
Target:	PDE
Pathway:	Store at -20°C
Storage:	A4327
Solvent & Solubility
In Vitro	insoluble in H2O; insoluble in EtOH;  ≥16.6 mg/mL in DMSO
	Preparing Stock Solutions	Mass		1mg		5mg	10mg
		Solvent
		Concentration
		1 mM		2.5681 mL		12.8403 mL	25.6805 mL
		5 mM		0.5136 mL		2.5681 mL	5.1361 mL
		10 mM		0.2568 mL		1.2840 mL	2.5681 mL
Biological Activity
In Vitro	Cell Viability Assay
	Cell Line:		human hepatocytes
	Preparation method：		The solubility of this compound in DMSO is >16.6mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20°C for several months.
	Reacting conditions:		1 pM
	Applications:		Tadalafil (1 μM) increased CYP3A protein expression in human hepatocytes.
In Vivo	Animal experiment
	Animal models:		Rat model with bilateral cavernous neurotomy (BCN)-induced penile damage and hypo-oxygenation, Mice with cavernous nerve resection
	Dosage form:		2 mg/kg, daily for 3 months
	Applications:		Tadalafil  (2  mg/kg)  almost  completely  restored  penile  oxygenation  and abolished neurotomy induced increase and substantially rescued muscle/fiber ratio in penile sectionsin sham-operated rats. Tadalafil decreased the number of  apoptotic  cells  and  increased  the  phosphorylation  of  the  2  survival associated kinases Akt and extracellular signal-regulated kinase 1/2 in mice.
	Other notes:		Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

Flow Chart

Using D-tryptophan as the raw material, the first methyl esterification reaction, the generated D-tryptophan methyl ester hydrochloride undergoes Pictet-spengler reaction with piperonal in isopropanol to obtain the cis-tetrahydrocarboline compound, Then it was reacted with chloroacetyl chloride and methylamine in sequence, and the total yield was 56%. After screening, glacial acetic acid was used as the recrystallization solvent for further purification. The specific reaction equation is as follows:
 

Description

Tadalafil bulk powder has a molecular formula of C22H19N3O4 and a molecular weight of 389.4. It has been widely used in the treatment of male erectile dysfunction since 2003, and its trade name is Cialis. In 2008, Eli Lilly and Company sold the commercial development rights of this product for PAH treatment to United Therapeutics. In June 2009, the FDA approved tadalafil for the treatment of patients with pulmonary arterial hypertension (PAH) in the United States under the trade name Adcirca. Tadalafil came out in 2003 as a drug for the treatment of ED.

It takes effect 30 minutes after administration, but its best effect is 2 hours after the onset of effect. The effect can last for 36 hours, and its effect is not affected by food. The dose of tadalafil is 10 or 20 mg, and the recommended initial dose is 10 mg. The dose adjustment is based on the patient's reaction and adverse reactions. Pre-market research shows that after 12 weeks of oral administration of 10 or 20 mg of tadalafil, the effective rates are 67% and 81%, respectively. Many studies have shown that tadalafil has a better effect in the treatment of ED.

Indications

Bulk Tadanafil powder is used to treat male erectile dysfunction (ED) and pulmonary hypertension.

Mechanism

Erectile dysfunction: Tadalafil and sildenafil belong to the same selective phosphodiesterase type 5 (PDE5), but its structure is different from the latter, and a high-fat diet will not interfere with its absorption. Under the action of sexual stimulation, nitric oxide synthase (NOS) in the nerve endings of the penis and vascular endothelial cells catalyzes the synthesis of nitric oxide (NO) from the substrate L-arginine. NO activates guanylate cyclase, which converts guanosine triphosphate into cyclic guanosine phosphate (cGMP), thereby activating cyclic guanosine phosphate-dependent protein kinase, resulting in a decrease in the calcium ion concentration in smooth muscle cells and causing the corpus cavernosum The smooth muscle relaxes and an erection occurs.

Phosphodiesterase type 5 (PDE5) degrades cGMP into a physiologically inactive product, turning the penis into a weak state. Tadalafil inhibits the degradation of PDE5, causes the accumulation of cGMP, relaxes the smooth muscles of the corpus cavernosum, and leads to erection of the penis. Since nitrates are NO donors, their combined use with tadalafil will significantly increase cGMP levels and cause severe hypotension. Therefore, the combined use of the two is contraindicated in clinical practice.